| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4b043c903ec3d696709ca6140213988 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B10-00 |
| filingDate |
2011-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43506008929111832798bf03399aba03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7aec5ee0699e3eff866ed9f58f3149cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4c084b50554d9bce62b77c225c4157c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_300541bdc45e380418e9c829a0b4ba6a |
| publicationDate |
2012-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
UA-68579-U |
| titleOfInvention |
METHOD FOR TUBEROSIS SCLEROSIS TREATMENT |
| abstract |
A method for the treatment of tuberous sclerosis by the correction of secondary mitochondrial insufficiency involves the appointment of energotropic drugs. Additionally determine the presence of polymorphisms of the folate cycle genes 677 C / T MTHFR and 66 A / G MTRR, in the presence of which patients are prescribed cofactor therapy: vitamin B6 (pyridoxine) at 50 mg / day, folic acid at 5 mg / day, cytarginine 1 oral vials per day for 2 weeks. |
| priorityDate |
2011-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |